The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study of docetaxel plus personalized peptide vaccination versus docetaxel plus placebo for patients previously treated for advanced wild-type EGFR non-small-cell lung cancer.
 
Shunichi Sugawara
No Relationships to Disclose
 
Koichi Takayama
Consulting or Advisory Role - Clinical Research Support Center Kyushu
Speakers' Bureau - AstraZeneca; Chugai Pharma; Lilly Japan; Pfizer
Research Funding - Chugai Pharma; Kyowa Hakko Kirin; Lilly Japan; Pfizer
 
Atsushi Sato
No Relationships to Disclose
 
Makoto Maemondo
No Relationships to Disclose
 
Shinzo Takamori
No Relationships to Disclose
 
Tetsuro Sasada
No Relationships to Disclose
 
Tatsuyuki Kakuma
No Relationships to Disclose
 
Junji Kishimoto
No Relationships to Disclose
 
Akira Yamada
Leadership - GreenPeptide
 
Masanori Noguchi
No Relationships to Disclose
 
Kyogo Itoh
Consulting or Advisory Role - Taiho pharmaceutical
Research Funding - Taiho pharmaceutical
 
Yoichi Nakanishi
No Relationships to Disclose